News - Generics, Warner Chilcott

Filter

Current filters:

GenericsWarner Chilcott

Popular Filters

FTC approves final order regarding Actavis’ acquisition of Warner Chilcott

FTC approves final order regarding Actavis’ acquisition of Warner Chilcott

12-12-2013

Following a public comment period, the US Federal Trade Commission has approved a final order settling…

ActavisGenericsMergers & AcquisitionsNorth AmericaRegulationReproductiveWarner Chilcott

Zydus Cadila settles Asacol patent litigation in USA

11-12-2013

Zydus Cadila, one of India’s largest privately-held pharmaceuticals companies, and affiliate Zydus…

ActavisAsacol HDGastro-intestinalsGenericsNorth AmericaPatentsWarner ChilcottZydus Cadila

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

22-11-2013

US generics major Actavis (NYSE: ACT) says it has completed the restructuring of its US Specialty Brands…

ActavisFinancialGenericsManagementNorth AmericaUSAWarner Chilcott

Actavis and Warner Chilcott to sell products to settle charges by FTC that their merger is 'uncompetitive'

Actavis and Warner Chilcott to sell products to settle charges by FTC that their merger is 'uncompetitive'

28-09-2013

Actavis has agreed to sell all rights and assets to four generic pharmaceuticals to settle US Federal…

ActavisAmneal PharmaAtelviaFemcon FeGenericsLegalLoestrin 24 FeMergers & AcquisitionsWarner ChilcottWomen's Health

Highs and lows as Actavis 2nd qtr results meet expectations

25-07-2013

US generics drug major Actavis (NYSE: ACT) reported its net revenue increased 46.8% to $1.99 billion…

ActavisFinancialGenericsNorth AmericaWarner Chilcott

Generics briefs: Actavis/Warner Chilcott M&A delay; Canasa patent challenge

11-07-2013

US generics major Actavis (NYSE: ACT) and Ireland-based Warner Chilcott (Nasdaq: WCRX) have each received…

ActavisAptalis PharmaCanasaGenericsLegalMergers & AcquisitionsMylan LaboratoriesNorth AmericaPatentsWarner Chilcott

Actavis confirms plan to acquire Warner Chilcott, in $8.5 billion deal

20-05-2013

US generics major Actavis (NYSE: ACT) revealed today (May 20) that it has entered into a definitive agreement…

ActavisGenericsMergers & AcquisitionsPharmaceuticalWarner ChilcottWomen's Health

Actavis and Warner Chilcott leap on merger talks; possible bid for Adcock Ingram

13-05-2013

US generics major Actavis NYSE: ACT) confirmed on Friday (May 10) that it has entered into early stage…

ActavisAdcock IngramFinancialGenericsMergers & AcquisitionsPharmaceuticalWarner Chilcott

FTC files amicus brief on pharma "product hopping"

27-11-2012

The USA's Federal Trade Commission revealed yesterday that it has filed an amicus brief before the US…

DoryxGenericsLegalNorth AmericaPharmaceuticalWarner Chilcott

Mylan confirms patent challenge to Generess Fe; launches Caduet copy in USA

02-12-2011

US generic drug major Mylan (Nasdaq: MYL) yesterday confirmed that it and Famy Care have been sued by…

CaduetCardio-vascularGeneress FeGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPatentsPfizerReproductiveWarner ChilcottWomen's Health

Mylan settles with Warner Chilcott over Femcon

19-10-2011

US generic drugmaker Mylan (Nasdaq: MYL) said yesterday that it, along with Famy Care, has entered into…

Femcon FeGenericsLegalMylan LaboratoriesNorth AmericaPatentsRespiratory and PulmonaryWarner Chilcott

Back to top